Butler expands Keytruda access, but not for all
By Megan Brodie 6 months ago | In Companies, Products, Reimbursement- 6 months ago
30 March 2026 The Federal Government has moved to fund MSD’s checkpoint inhibitor KEYTRUDA (pembrolizumab)…
This is subscriber-only content. Please login to continue reading.